Abstract
Protein aggregation has a multitude of consequences ranging from affecting protein expression to its implication in different diseases. Of recent interest is the specific form of aggregation leading to the formation of amyloid fibrils, structures associated with diseases such as Alzheimer's disease. These fibrils can further associate in other more complex structures such as fibrillar gels, plaques, or spherulitic structures. In the present work, we describe the physical and structural properties of additional supraself-assembled structures of human serum albumin under solution conditions in which amyloid-like fibrils are formed. We have detected the formation of ordered aggregates of amyloid fibrils, i.e., spherulites which possess a radial arrangement of the fibrils around a disorganized protein core and sizes of several micrometers by means of polarized optical microscopy, laser confocal microscopy, and transmission electron microscopy. These spherulites are detected both in solution and embedded in an isotropic matrix of fibrillar gels. In this regard, we have also noted the formation of protein gels when the protein concentration and/or ionic strength exceds a threshold value (the gelation point) as observed by rheometry. Fibrillar gels are formed through intermolecular nonspecific association of amyloid fibrils at a pH far away from the isolectric point of the protein where protein molecules seem to display a "solid-like" behavior due to the existence of non-DLVO (Derjaguin-Landau-Verwey-Overbeck) intermolecular repulsive forces. As the solution ionic strength increases, a coarsening of this type of gel is observed by environmental scanning microscopy. In contrast, at pH close to the protein isoelectric point, particulate gels are formed due to a faster aggregation process, which does not allow substantial structural reorganization to enable the formation of ordered structures. This behavior also additionally corroborates that the existence of particulates might also be a generic property of all polypeptide chains as amyloid fibril formation under suitable conditions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.